Moderna partnering with IAVI to use mRNA on HIV/AIDS, tuberculosis, infections

Photo Credit: Anna Shvets. Photo Sourced From: Pexels

Moderna (NASDAQ:MRNA) is partnering with scientific research organization IAVI to utilize the company’s mRNA technology to discover antibodies and treatments for HIV/AIDS, tuberculosis (“TB”), antimicrobial-resistant infections, and COVID-19.
IAVI currently has an HIV vaccine in development that uses HIV antigens delivered by mRNA. A phase 1 trial began in January.
An earlier trial showed the vaccine induced a B cell response in 97% of recipients.
Programs including a TB vaccine candidate and antibodies for SARS-CoV-2 and enteric pathogens are in preclinical development.
Recently, Moderna (MRNA) CEO Stephane Bancel predicted that many adults will get annual COVID vaccine boosters.

Naturally Inspired Media Shares Various Videos, Audios, Podcasts, Music, Images, Articles, Shows etc… from other sources from time to time. Please support these other sources for their creative work. CLICK HERE FOR OUR FAIR USE DISCLAIMER

Please Share This World Wide

Citizen Journalism Is Under Attack! Naturally Inspired Media Has Been Shadow Banned And Censored And Needs Your Help To Share This Critical Information. Our Lives And Freedom Depend On It!

Tip/Donate Today! $5 – $10 – $25 – $50 – $100

Thank You For Helping Us Help Others Live Their Best Life.

Tammy Cuthbert Garcia

Tammy Cuthbert Garcia is an organic lifestyle entrepreneur, podcast host, radio show personality, health writer and spokesperson for health freedom. She began hosting “Naturally Inspired Podcast” in 2019 where she interviews top minds in lifestyle solutions and health freedom. She makes guest host appearances on AM/FM radio and also has a daily show called “Naturally Inspired Daily”.